Hafner
Alexis Hafner, Paris FR
Patent application number | Description | Published |
---|---|---|
20140359309 | DELETION OF CONTENT IN STORAGE SYSTEMS - The invention notably relates to a computerized system ( | 12-04-2014 |
Andreas Hafner, Gelterkinden Bl CH
Patent application number | Description | Published |
---|---|---|
20120309036 | Test Arrangement - The invention relates to an arrangement, comprising a solid carrier and a matrix arranged on the solid carrier, said matrix comprising at least one enzymatically convertible or modifiable molecule and comprising at least one enzyme that can be released by the conversion or modification of the molecule, said enzyme being capable of converting at least one color-changing substrate located in the matrix and/or on the solid carrier. | 12-06-2012 |
Andreas Hafner, Gelterkinden CH
Patent application number | Description | Published |
---|---|---|
20110159050 | AMPHIPHILIC PROTEINS AS MORPHOLOGY MODIFIERS - Disclosed is a process for modifying the morphology and/or polymorphism of an organic substance, which process comprises treating the solid substance, or a solution or dispersion thereof, with one or more amphiphilic proteins. | 06-30-2011 |
20110268792 | SURFACE ACTIVE PROTEINS AS EXCIPIENTS IN SOLID PHARMACEUTICAL FORMULATIONS - The invention relates to a use of surface active hydrophobins for applications in pharmaceutical technology, in particular as excipients for galenic use. Provided is a method for either admixture of hydrophobins to galenic compositions or for treating the surface of pharmaceutical forms with a hydrophobin-containing solution to modify the pharmaceutical properties of the galenic form. In a preferred embodiment of the invention hydrophobins are used to improve the properties of a pharmaceutical composition, e.g. to act as a surfactant or to increase resistance to disintegration of the galenic forms to achieve a retarded drug release. The galenic form to be modified by the use of surface active proteins as excipients can be capsules, tablets, pills, microparticles, vesicles, and suppositories, although further galenic forms are envisioned. The surface active proteins used for the purpose of present invention can either be isolated from their respective natural source or prepared by recombinant techniques and expression in a suitable host. | 11-03-2011 |
20120058199 | COMPOSITIONS, USE AND METHOD FOR THE USE OF SURFACE ACTIVE PROTEINS IN TOPICAL DRUG DELIVERY ACROSS KERATIN - The present invention provides the use of surface active proteins, especially class I and class II hydrophobins, in topically applied pharmaceutical formulations. The invention is particularly directed to topically applied pharmaceutical products for enhancing the penetration to achieve a transungual delivery of a prophylactically and/or therapeutically effective amount of an active ingredient (drug) to a patient (including animals and humans) into and/or through a nail, of the animal or human body, in order to treat one or more of a variety of diseases or disorders. Related embodiments of the invention are also disclosed. | 03-08-2012 |
20120164162 | METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES - A method for the manufacture of products by biotechnological methods in bacterial cell culture is disclosed as well as products obtained, the use of certain additives to the media used in the manufacture of said products in bacterial cell culture media, and the use of said additives in reducing the detrimental effects of radicals in the manufacture of the products, as well as aspects related to these invention embodiments. The manufacturing process or method comprises adding one or more radical scavenging and/or antioxidative additive preferably selected from the group consisting of sterically hindered nitroxyls, sterically hindered hydroxylamines, sterically hindered hydroxylamine salt compounds, sterically hindered amino compounds and sterically hindered N-hydrocarbyloxyamines, benzofuranone compounds, as obligatory component(s) to the medium used during biosynthesis. | 06-28-2012 |
20130237553 | MULTICOMPONENT SYSTEM OF RESUVASTATIN CALCIUM SALT AND SORBITOL - A novel solid form of Rosuvastatin comprises as the active ingredient a salt of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)-amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid] and sorbitol. The crystal comprising the two components, and minor amounts of water, shows improved properties such as crystal-lization behaviour and stability. | 09-12-2013 |
20140031377 | MULTICOMPONENT CRYSTALLINE SYSTEM OF ROSUVASTATIN CALCIUM SALT AND VANILLIN - A novel solid form of Rosuvastatin comprises as the active ingredient a salt of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)-amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid] and vanillin or vanillin derivatives. The crystal comprising the two components, and minor amounts of water, shows improved properties such as crystallization behavior stability and decreased hydroscopic behavior. | 01-30-2014 |
20140155371 | MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE - Provided is a crystalline composition comprising a mixture of a compound of formula 1 (Ezetimibe) and proline or proline derivatives, or a hydrate/solvate thereof, as well as a process for obtaining the same. And a process for the purification of Ezetimibe is also disclosed. | 06-05-2014 |
20140194453 | MULTICOMPONENT CRYSTALLINE SYSTEM OF ROSUVASTATIN CALCIUM SALT AND VANILLIN - A novel solid form of Rosuvastatin comprises as the active ingredient a salt of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)-amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid] and vanillin or vanillin derivatives. The crystal comprising the two components, and minor amounts of water, shows improved properties such as crystallization behavior stability and decreased hydroscopic behavior. | 07-10-2014 |
20150087657 | MULTICOMPONENT CRYSTALLINE SYSTEM OF VORICONAZOLE WITH FUMARIC ACID - A novel solid form of Voriconazole comprises the active ingredient (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol and fumaric acid. The solid composition comprising the two components shows improved properties such as water solubility, crystallization behavior and stability. | 03-26-2015 |
20150126520 | MULTICOMPONENT CRYSTALS COMPRISING IMATINIB MESILATE AND SELECTED CO-CRYSTAL FORMERS - Novel solid forms of imatinib mesilate comprising as active ingredient 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]-benzamide methanesulfonic acid salt and as co-crystal former benzoic acid, fumaric acid or succinic acid are described. The said multi-component crystalline forms possess improved physical and biological properties with respect to the crystalline forms of the active pharmaceutical ingredient previously known. | 05-07-2015 |
20150133463 | MULTICOMPONENT CRYSTALS COMPRISING DASATINIB AND SELECTED CO-CRYSTAL FORMERS - Provided are a multicomponent crystalline system (co-crystal), use thereof, as well as a process for obtaining the same. The said multicomponent crystalline system (co-crystal) comprises Dasatinib and a second compound selected from methyM-hydrobenzoate, nicotinamide, ethyl gallate, methyl gallate, propyl gallate, ethyl maltol, vanillin, menthol, or (1R,2S,5R)-(−)-menthol. | 05-14-2015 |
20150175544 | MULTICOMPONENT CRYSTALLINE SYSTEM COMPRISING DEFERASIROX AND ISONICOTINAMIDE AND A PROCESS FOR THE PREPARATION THEREOF - The present invention refers to a multicomponent crystalline system (co-crystal) comprising a compound of formula (1) (4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; INN: Deferasirox) formula (1) and a compound of formula (2) (Isonicotinamide; pyridine-4-carboxamide) formula (2), as well as to a process for obtaining the same. | 06-25-2015 |
20150246901 | MULTICOMPONENT CRYSTALLINE SYSTEM COMPRISING NILOTINIB AND SELECTED CO-CRYSTAL FORMERS - The present invention relates to crystalline materials comprising nilotinib and a carboxylic acid, carboxylic acid ester, carboxylic acid amide or sulfonic acid as a co-crystal former, and to pharmaceutical compositions comprising said materials. The invention also relates to processes for preparing said crystalline materials and to methods of using said crystalline materials to treat a disease condition in which tyrosine kinase inhibition is beneficial. | 09-03-2015 |
Christine Häfner, Zwickau DE
Patent application number | Description | Published |
---|---|---|
20100206984 | Bearing Application for Fastening Step Flights in an Aircraft - The invention relates to a bearing application for staircases in an aircraft with at least two decks. | 08-19-2010 |
Christine Häfner, Zwickau DE
Patent application number | Description | Published |
---|---|---|
20100206984 | Bearing Application for Fastening Step Flights in an Aircraft - The invention relates to a bearing application for staircases in an aircraft with at least two decks. | 08-19-2010 |
Dieter Hafner, Tübingen DE
Patent application number | Description | Published |
---|---|---|
20100016879 | TUBULAR SHAFT INSTRUMENT - The present application relates to a tubular shaft instrument for separating tissue. The invention relates to a tubular shaft instrument that results in more reliable, cleaner separation of tissue. To achieve this, in contrast to conventional cutting devices, the blade is not displaced through the fixed tissue, but glides over the latter until a complete separation is ascertained. | 01-21-2010 |
Greg John Hafner, Carina AU
Patent application number | Description | Published |
---|---|---|
20110119782 | CONSTRUCT CAPABLE OF RELEASE IN CLOSED CIRCULAR FORM FROM A LARGER NUCLEOTIDE SEQUENCE PERMITTING SITE SPECIFIC EXPRESSION AND/OR DEVELOPMENTALLY REGULATED EXPRESSION OF SELECTED GENETIC SEQUENCES - The present invention relates generally to constructs and in particular genetic constructs comprising polynucleotide sequences capable of release in covalently closed, circular form from a larger nucleotide sequence such as, but not limited to, a genome of a eukaryotic cell. Preferably, once released, a polynucleotide sequence is reconstituted in a form which permits expression of the polynucleotide sequence. In one embodiment, the reconstituted polynucleotide sequence comprises a coding sequence with all or part of an extraneous nucleotide such as, but not limited to, an intronic sequence or other splice signal inserted therein. Expression and in particular transcription of the coding sequence involves splicing out the extraneous sequence. The release and circularization is generally in response to a stimulus such as a protein-mediated stimulus. More particularly, the protein is a viral or prokaryotic or eukaryotic derived protein or developmentally and/or tissue specific regulated protein. | 05-19-2011 |
Gregory John Hafner, Wynnum AU
Patent application number | Description | Published |
---|---|---|
20100281566 | TRANSCRIPTIONAL CONTROL ELEMENT, CHIMERIC CONSRUCTS AND USES THEREFOR - This invention discloses a constitutive promoter for expression of foreign or endogenous coding sequences in plants, including dicotyledonous and monocotyledonous plants. The invention also discloses a chimeric nucleic acid construct comprising the promoter of the invention operably linked to a foreign or endogenous polynucleotide that codes for a protein of interest or a transcript capable of modulating expression of a target gene. The invention further discloses transformed plant cells, as well as differentiated plants and plant parts, containing the construct. Methods for diagnosis and treatment of viral infections, especially badnaviral infections, are also disclosed. | 11-04-2010 |
Jochen Häfner, Lorch DE
Patent application number | Description | Published |
---|---|---|
20100037847 | Internal combustion engine comprising several combustion chambers - In an internal combustion engine having several combustion chambers formed in in-line cylinders wherein an air/fuel mixture can be combusted and which include a common cylinder head, with discharge passages formed within the cylinder head and extending to a common confluence zone in communication with a discharge manifold, the common confluence zone is delimited on a first side (A) by at least one cylinder head wall and a separate shell element on a second side mounted to the outside of the cylinder head, the shell element being curved funnel-like for conducting the exhaust gas away from the engine. | 02-18-2010 |
Jochen Häfner, Lorch DE
Patent application number | Description | Published |
---|---|---|
20100037847 | Internal combustion engine comprising several combustion chambers - In an internal combustion engine having several combustion chambers formed in in-line cylinders wherein an air/fuel mixture can be combusted and which include a common cylinder head, with discharge passages formed within the cylinder head and extending to a common confluence zone in communication with a discharge manifold, the common confluence zone is delimited on a first side (A) by at least one cylinder head wall and a separate shell element on a second side mounted to the outside of the cylinder head, the shell element being curved funnel-like for conducting the exhaust gas away from the engine. | 02-18-2010 |
Josef Hafner, Künten CH
Patent application number | Description | Published |
---|---|---|
20100247309 | LAMELLAR SEAL FOR A TURBOMACHINE - A lamellar seal for sealing a shaft which rotates around an axis, especially in a gas turbine, includes a multiplicity of lamella ( | 09-30-2010 |
Josef Hafner, Künten CH
Patent application number | Description | Published |
---|---|---|
20100247309 | LAMELLAR SEAL FOR A TURBOMACHINE - A lamellar seal for sealing a shaft which rotates around an axis, especially in a gas turbine, includes a multiplicity of lamella ( | 09-30-2010 |
Josef Thomas Hafner, Rorschacherberg CH
Patent application number | Description | Published |
---|---|---|
20130012349 | GEAR TRAIN UNIT AND ARRANGEMENT FOR A STAMPING PRESS - The invention relates to a gear train unit comprising a plurality of planetary gear train stages, which are connected one after the other and which each comprise a ring gear ( | 01-10-2013 |
Josef Thomas Hafner, Bundesland CH
Patent application number | Description | Published |
---|---|---|
20100206187 | PUNCHING PRESS - The invention relates to a punching press with a clamping plate ( | 08-19-2010 |
Jurgen Häfner, Ludvika SE
Patent application number | Description | Published |
---|---|---|
20130038975 | HIGH VOLTAGE DC BREAKER APPARATUS - A high voltage DC breaker apparatus configured to break a fault current occurring in a high voltage DC conductor includes a current limiting arrangement having at least one section with at least one semiconductor device of turn-off type and at least one arrester connected in parallel therewith, and a mechanical DC breaker connected in series with the current limiting arrangement and including a mechanical switch. The mechanical DC breaker is configured to enable breaking of a fault current in said DC conductor once said semiconductor devices of said arrangement have been turned off. | 02-14-2013 |
20130050888 | HIGH VOLTAGE DC SWITCHYARD WITH SEMICONDUCTOR SWITCHES - A high voltage DC switchyard comprises at least one busbar, at lest two DC lines connected to said at least one busbar through DC breakers comprising a section of at least one semiconductor device of turn-off type and rectifying member in anti-parallel therewith. At least one said DC line is connected to at least one said busbar through a unidirectional said DC breaker, i.e. a DC breaker that may only block current therethrough in one direction. | 02-28-2013 |
Jürgen Häfner, Ludvika SE
Patent application number | Description | Published |
---|---|---|
20120299393 | DEVICE AND METHOD TO BREAK THE CURRENT OF A POWER TRANSMISSION OR DISTRIBUTION LINE AND CURRENT LIMITING ARRANGEMENT | 11-29-2012 |
20130009491 | SWITCHING MODULE FOR USE IN A DEVICE TO LIMIT AND/OR BREAK THE CURRENT OF A POWER TRANSMISSION OR DISTRIBUTION LINE - A switching module, intended to be used in a medium or high voltage DC breaker or a DC current limiter, includes at least one power semiconductor switching element, a gate unit arranged to turn the at least one power semiconductor switching element on and off, respectively, according to a switching control signal, and an energy storage capacitor arranged to provide power to a power supply input of the gate unit. The switching module further includes a power transformation device arranged to receive an optical power signal, to transform the optical power signal into an electrical power signal and to provide the electrical power signal to the energy storage capacitor. | 01-10-2013 |
Louise Hafner, Queensland AU
Patent application number | Description | Published |
---|---|---|
20090028891 | Chlamydia Antigens and Uses Thereof - The invention provides protein and nucleic acid sequences of | 01-29-2009 |
Martin Hafner, Vienna AT
Patent application number | Description | Published |
---|---|---|
20110020402 | Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen - Described is a method for identification, isolation and production of hyperimmune serum-reactive antigens from a specific pathogen, a tumor, an allergen or a tissue or host prone to autoimmunity, said antigens being suited for use in a vaccine for a given type of animal or for humans, which is characterized by the following steps:—providing an antibody preparation from a plasma pool of said given type of animal or from a human plasma pool or individual sera with antibodies against said specific pathogren, tumor, allergen or tissue or host prone to auto-immunity,—providing at least one expression library of said specific pathogen, tumor, allergen or tissue or host prone to auto-immunity,—screening said at least one expression library with said antibody preparation, identifying antigens which bind in said screening to antibodies in said antibody preparation, —screening the identified antigens with individual antibody preparations from individual sera from individuals with antibodies against said specific pathogen, tumor, allergen or tissue or host prone to auto-immunity,—identifying the hyperimmune serum-reactive antigen portion of said identified antigens and which hyperimmune serum-reactive antigens bind to a relevant portion of said individual antibody preparations from said individual sera and—optionally isolating said hyperimmune serum-reactive antigens and producing said hyperimmune serum-reactive antigens by chemical or recombinant methods. | 01-27-2011 |
20130034575 | METHOD FOR IDENTIFICATION, ISOLATION AND PRODUCTION OF ANTIGENS TO A SPECIFIC PATHOGEN - Described is a method for identification, isolation and production of hyperimmune serum-reactive antigens from a specific pathogen, a tumor, an allergen or a tissue or host prone to auto-immunity, said antigens being suited for use in a vaccine for a given type of animal or for humans, which is characterized by the following steps: providing an antibody preparation, providing at least one expression library, identifying antigens which bind, screening the identified antigens, identifying the hyperimmune serum-reactive antigen portion of said identified antigens and which hyperimmune serum-reactive antigens bind to a relevant portion of said individual antibody optionally isolating said hyperimmune serum-reactive antigens and producing said hyperimmune serum-reactive antigens by chemical or recombinant methods. | 02-07-2013 |
Norbert Hafner, Linz AT
Patent application number | Description | Published |
---|---|---|
20110104416 | PROPYLENE-HEXENE RANDOM COPOLYMER PRODUCED IN THE PRESENCE OF A ZIEGLER NATTA CATALYST - Propylene copolymer a. comprising at least 1-hexene as a comonomer, b. having a comonomer content in the range of 1.0 to 3.0 wt.-%, c. having a xylene soluble fraction equal or below 2.5 wt.-%, and d. being partially crystallized in the β-modification. | 05-05-2011 |
20110293867 | Propylene-butene random copolymer produced in the presence of a metallocene catalyst - Propylene copolymer (a) comprising at least 1-butene as a comonomer, (b) having a comonomer content in the range of 1.0 to 3.0 wt.-%, (c) having a xylene soluble fraction equal or below 2.5 wt.-%, and (d) being partially crystallized in the β-modification. | 12-01-2011 |
20110315264 | Propylene-hexene random copolymer produced in the presence of a metallocene catalyst - Propylene copolymer a. comprising at least 1-hexene as a comonomer, b. having a comonomer content in the range of 1.0 to 3.0 wt.-%, c. having a xylene soluble fraction equal or below 2.5 wt.-%, d. having a polydispersity index (PI) of equal or below 4.0 Pa | 12-29-2011 |
20130131291 | SOLID PARTICULATE CATALYSTS COMPRISING BRIDGED METALLOCENES - A polypropylene homopolymer with a melting point of less than 147° C., a percentage of 2.1 errors of at least 1% and a xylene soluble fraction of less than 0.5 wt %. | 05-23-2013 |
20140079899 | PROPYLENE-HEXENE RANDOM COPOLYMER PRODUCED IN THE PRESENCE OF A ZIEGLER NATTA CATALYST - Propylene copolymer a. comprising at least 1-hexene as a comonomer, b. having a comonomer content in the range of 1.0 to 3.0 wt.-%, c. having a xylene soluble fraction equal or below 2.5 wt.-%, and d. being partially crystallized in the β-modification. | 03-20-2014 |
20140206819 | HETEROPHASIC COPOLYMERS - A heterophasic polypropylene resin comprising a polypropylene homopolymer matrix phase (A) and an ethylene-propylene copolymer phase (B) dispersed within the matrix, wherein the xylene soluble fraction of the heterophasic polypropylene resin is in the range 20 to less than 50 wt %; the heterophasic polypropylene resin has an MFR2 of 0.01 to 50 g/10 min; the ethylene content of the xylene soluble fraction of the heterophasic polypropylene resin is in the range of at least 20 wt % to less than 50 wt %; the heterophasic polypropylene resin has a notched charpy impact strength at −20 C of at least 25 kJ/m | 07-24-2014 |
20140221584 | CATALYSTS - A racemic complex of formula (I), wherein M is zirconium or hafnium; each X is a sigma ligand; L is a divalent bridge selected from —R′ | 08-07-2014 |
Norbert Häfner, Lappersdorf DE
Patent application number | Description | Published |
---|---|---|
20130249396 | LUMINOUS DEVICE COMPRISING MULTIPLE SPACED-APART EMISSION REGIONS - A luminous device includes at least one radiation-emitting semiconductor chip including at least two emission regions arranged spaced apart in a lateral direction, wherein each emission region includes at least one active zone that emits electromagnetic radiation; and a drive device that operates the emission regions. | 09-26-2013 |
Norbert Häfner, Lappersdorf DE
Patent application number | Description | Published |
---|---|---|
20130249396 | LUMINOUS DEVICE COMPRISING MULTIPLE SPACED-APART EMISSION REGIONS - A luminous device includes at least one radiation-emitting semiconductor chip including at least two emission regions arranged spaced apart in a lateral direction, wherein each emission region includes at least one active zone that emits electromagnetic radiation; and a drive device that operates the emission regions. | 09-26-2013 |
Peter Roderick Hafner, Wiltshire GB
Patent application number | Description | Published |
---|---|---|
20100035805 | NON-AQUEOUS LIQUID FORMULATION FOR NASAL OR BUCCAL ADMINISTRATION - A formulation for administration to a nasal or buccal cavity of a subject which comprises a non-aqueous liquid environment, preferably an emollient oil base, and at least one active molecule, preferably a dopamine agonist and especially apomorphine, in solution or suspension therein, wherein in one embodiment the formulation has such a viscosity as to be delivered as a liquid jet from a spray pump which is capable of delivering an aerosol spray of an aqueous formulation. | 02-11-2010 |
20140144442 | NASAL ADMINISTRATION - A delivery device for and method of providing for delivery of substance to the central nervous system (CNS) of a subject, the delivery device comprising: a nosepiece unit for insertion into a nasal airway of a subject and comprising an outlet unit which includes a nozzle for delivering substance into the nasal airway of the subject; and a substance supply unit which is operable to deliver a dose of substance to the nozzle; wherein the delivery device is configured such that at least 30% of the dose as initially deposited in the nasal airway is deposited in an upper posterior region of the nasal airway, thereby providing a CNS concentration of the substance, and hence CNS effect, which is significantly greater than that which would be predicted from a counterpart blood plasma concentration of the substance. | 05-29-2014 |
20140144443 | NASAL ADMINISTRATION - A delivery device for and method of providing for delivery of substance to the central nervous system (CNS) of a subject, the delivery device comprising: a nosepiece unit for insertion into a nasal airway of a subject and comprising an outlet unit which includes a nozzle for delivering substance into the nasal airway of the subject; and a substance supply unit which is operable to deliver a dose of substance to the nozzle; wherein the delivery device is configured such that at least 30% of the dose as initially deposited in the nasal airway is deposited in an upper posterior region of the nasal airway, thereby providing a CNS concentration of the substance, and hence CNS effect, which is significantly greater than that which would be predicted from a counterpart blood plasma concentration of the substance. | 05-29-2014 |
Roland Hafner, Uzwil CH
Patent application number | Description | Published |
---|---|---|
20150337967 | EXPLOSION-PROOF SLIDING GATE VALVE FOR BLOCKING A FLUID FLOW IN A PIPELINE - An explosion-proof sliding gate valve ( | 11-26-2015 |
Stefan Häfner, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20100015674 | Methods For The Preparation of Lysine By Fermentation Of Corynebacterium Glutamicum - The present invention features methods of increasing the production of a fine chemical, e.g., lysine from a microorganism, e.g., | 01-21-2010 |
Stefan Häfner, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20080280333 | Use of the repressor glxR for the synthesis of lysine in corynebacterium glutamicum - Isolated polypeptide sequence having the sequence of SEQ ID NO:1 or muteins thereof having the ability to bind cAMP and repress the expression of the aceB gene of | 11-13-2008 |
20100015674 | Methods For The Preparation of Lysine By Fermentation Of Corynebacterium Glutamicum - The present invention features methods of increasing the production of a fine chemical, e.g., lysine from a microorganism, e.g., | 01-21-2010 |
Stefan Häfner, Speyer DE
Patent application number | Description | Published |
---|---|---|
20120028333 | USE OF ENZYMES TO REDUCE ALDEHYDES FROM ALDEHYDE-CONTAINING PRODUCTS - The invention relates to the use of an enzyme preparation which catalyzes the degradation of formaldehyde for reducing the formaldehyde content in a formaldehyde-containing formulation. In a preferred embodiment, the enzyme preparation contains a formaldehyde dismutase from a | 02-02-2012 |
Thomas Hafner, Kuala Lumpur MY
Patent application number | Description | Published |
---|---|---|
20130059817 | COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT - This invention relates to compositions for reducing the absorption or bioavailability of lipids in the gastrointestinal tract, and to methods for the preparation and use of these compositions. The compositions comprise a source of dietary fibre together with a cyclodextrin. The compositions of the invention are suitable for use in the prevention and treatment of obesity or hyperlipidaemia. | 03-07-2013 |
Tobias Hafner, Muri CH
Patent application number | Description | Published |
---|---|---|
20110284344 | SYSTEM FOR SUPPLYING COMPONENTS | 11-24-2011 |
Urs Hafner, Kunten Ag CH
Patent application number | Description | Published |
---|---|---|
20130333201 | METHOD AND DEVICE FOR EXTRACTION OR INTRODUCTION OF A ROTOR FROM OR INTO A STATOR OF AN ELECTRIC MACHINE - The method for extraction or introduction of a rotor ( | 12-19-2013 |
Valeria Hafner, Geneva CH
Patent application number | Description | Published |
---|---|---|
20130064931 | INGREDIENT DELIVERY SYSTEM - A delivery system that includes surfactant micelles, and a surfactant system of nonionic, cationic or zwitterionic surfactants, with the surfactant being present in an amount equal to or greater than its critical micelle concentration, 10% or more by weight, based on the total weight of the delivery system, of a hydrophilic phase formed of water and/or a water-soluble solvent, and from 0.0001 to 5% by weight, based on the total weight of the delivery system, of a compound having the structure | 03-14-2013 |
20150322374 | ETHANOL-FREE MICROEMULSION PERFUMING COMPOSITIONS - The present invention provides a perfuming composition that is free of ethanol and that is in the form of a transparent, clear microemulsion that contains a fragrance at a concentration of 0.5 to 50% by weight; a solvent at a concentration of 1 to 36% by weight; a non-ionic surfactant at a concentration of 1 to 35% by weight; an ionic surfactant at a concentration of 0 to 12% by weight, a cooling hydrotrope at a concentration of 0.01 to 12% by weight and water. Said microemulsions benefit from the presence of a cooling hydrotrope which allows lowering the amount of surfactant needed and provides a cooling effect. | 11-12-2015 |
Valeria Hafner, Geneva 8 CH
Patent application number | Description | Published |
---|---|---|
20130004615 | PREPARATION OF SOLID CAPSULES COMPRISING FLAVOURS - The present invention relates to a process for the preparation of solid capsules that contain flavours therein, by spray drying of an emulsion of a flavour or fragrance, a natural extract of saponins, water and a water-soluble biopolymer having a molecular weight below 100 KDa. The invention further relates to the solid capsules obtainable by the method and to edible products containing them. | 01-03-2013 |
Volker Häfner, Langenselbold DE
Patent application number | Description | Published |
---|---|---|
20090192309 | PROCESS FOR PREPARING TRIALLYL CYANURATE - The invention relates to an improved process for preparing triallyl cyanurate (TAC) by reacting cyanuric chloride with allyl alcohol in the presence of an alkali metal acid acceptor and in the absence of an organic solvent other than allyl alcohol. According to the invention, TAC is obtained in over 99% purity with an APHA colour number below 10 in a yield of over 90% when 3.9 to 6.0 mol of allyl alcohol and 3.0 to 3.2 equivalents of acid acceptor are used per mole of cyanuric chloride, cyanuric chloride and acid acceptor are added simultaneously or successively to anhydrous or at least 50% by weight aqueous allyl alcohol, and the reaction is performed in one or more stages at a temperature in the range of −5 to +50° C. | 07-30-2009 |
Volker Häfner, Langenselbold DE
Patent application number | Description | Published |
---|---|---|
20090192309 | PROCESS FOR PREPARING TRIALLYL CYANURATE - The invention relates to an improved process for preparing triallyl cyanurate (TAC) by reacting cyanuric chloride with allyl alcohol in the presence of an alkali metal acid acceptor and in the absence of an organic solvent other than allyl alcohol. According to the invention, TAC is obtained in over 99% purity with an APHA colour number below 10 in a yield of over 90% when 3.9 to 6.0 mol of allyl alcohol and 3.0 to 3.2 equivalents of acid acceptor are used per mole of cyanuric chloride, cyanuric chloride and acid acceptor are added simultaneously or successively to anhydrous or at least 50% by weight aqueous allyl alcohol, and the reaction is performed in one or more stages at a temperature in the range of −5 to +50° C. | 07-30-2009 |